Active Ingredient History
Leflunomide, sold under the brand name Arava among others, is an immunosuppressive disease-modifying antirheumatic drug (DMARD), used in active moderate-to-severe rheumatoid arthritis and psoriatic arthritis. It is a pyrimidine synthesis inhibitor that works by inhibiting dihydroorotate dehydrogenase. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Arthritis, Juvenile (Phase 4)
Arthritis, Psoriatic (Phase 4)
Brain Neoplasms (Phase 3)
Breast Diseases (Phase 1/Phase 2)
Breast Neoplasms (Phase 1/Phase 2)
COVID-19 (Phase 3)
Drugs, Generic (Phase 1)
Glioma (Phase 1)
Glomerulonephritis, IGA (Phase 4)
Graft vs Host Disease (Phase 2)
Healthy Volunteers (Phase 1)
Hepatitis C (Phase 2)
HIV Infections (Phase 1)
Immunoglobulin G4-Related Disease (Phase 4)
Infections (Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Lupus Nephritis (Phase 3)
Lymphoma (Phase 1/Phase 2)
Lymphoproliferative Disorders (Phase 2)
Melanoma (Phase 1)
Multiple Myeloma (Phase 2)
Musculoskeletal Diseases (Phase 2)
Myasthenia Gravis (Phase 3)
Neoplasms (Phase 1/Phase 2)
Pemphigoid, Bullous (Phase 2)
Polymyalgia Rheumatica (Phase 3)
Prostatic Neoplasms (Phase 2/Phase 3)
Purpura (Phase 2)
Renal Insufficiency, Chronic (Phase 4)
Sarcoma (Phase 1)
Sjogren's Syndrome (Phase 2)
Still's Disease, Adult-Onset (Phase 2)
Substance Withdrawal Syndrome (Phase 3)
Uveitis (Phase 2)
Viremia (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue